Abbott Laboratories (ABT) Tax Provisions (2009 - 2026)

Abbott Laboratories has disclosed Tax Provisions across 18 years of filings, most recently posting $596.0 million for Q2 2026.

• In Q2 2026, Tax Provisions rose 60.65% year-over-year to $596.0 million; the TTM figure through Jun 2026 stood at $2.1 billion (up 134.3% YoY), while the FY2025 annual figure was $1.9 billion, up 130.4% from the prior year.
• Tax Provisions came in at $596.0 million for Q2 2026 at Abbott Laboratories, up from $372.0 million in the prior quarter.
• In the past five years, Tax Provisions ranged from a high of $596.0 million in Q2 2026 to a low of -$7.2 billion in Q4 2024.
• Average Tax Provisions over 5 years is -$64.7 million, with a median of $314.0 million recorded in 2022.
• Year-over-year, Tax Provisions sank 3681.59% in 2024 and surged 114.69% in 2025.
• Over 5 years, Tax Provisions stood at $287.0 million in 2022, then declined by 29.97% to $201.0 million in 2023, then slumped by 3681.59% to -$7.2 billion in 2024, then surged by 108.08% to $582.0 million in 2025, then climbed by 2.41% to $596.0 million in 2026.
• Per Business Quant data, the three most recent Tax Provisions figures were $596.0 million in Q2 2026, $372.0 million in Q1 2026, and $582.0 million in Q4 2025.